-
foundation for an independent research trajectory. REGAL is a multidisciplinary research program integrating social epidemiology, molecular epidemiology, and global health to investigate the drivers of cancer
-
September 1, 2026 Position Summary The SCALES (Scholars for Climate and Advanced Leadership in Environment and Sustainability) Postdoctoral Fellows Program at Duke University seeks early-career scholars
-
. The investigator collaborates with interdisciplinary clinical teams to integrate these computational tools directly into hospital workflows. Routine duties include algorithm optimization and the evaluation of model
-
, United States of America [map ] Subject Areas: Biological Sciences Biostatistics Health Informatics or Bioinformatics Public Health Epidemiology (more...) Climate Science Environmental Analysis Appl Deadline: (posted 2026
-
—induced by targeted drugs—can serve as a powerful therapeutic avenue in prostate cancer. Working under the mentorship of a Duke faculty leader, you will develop your independent research program, contribute
-
Position Description POSITION SUMMARY: The SCALES (Scholars for Climate and Advanced Leadership in Environment and Sustainability) Postdoctoral Fellows Program at Duke University seeks early-career scholars
-
: Leveraging big data and computational methods to analyze adaptation behaviors and incorporate its costs and benefits into climate impact assessments. • Adaptation of Places: Partnering with natural scientists
-
multiple affiliations. Postdoctoral FellowPosition Computational approaches to malaria parasite antigen diversity Duke Global Health Institute Be You. The Malaria Collaboratory is recruiting an exceptional
-
primary benefit. This postdoctoral appointment is part of the Duke University Aging Center’s NIA-funded T32 Postdoctoral Research Training Program. This multidisciplinary program is focused on developing
-
multiple affiliations. Computational Immunobiology Postdoctoral Associate Position (Williams) Be You. The Duke Human Vaccine Institute (DHVI) continues to lead cutting edge vaccine research against